American National Bank & Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VF
AT
CISOA
DJSG
MIF
CIM
American National Bank & Trust's RMD Position: Q2 2026 in Review
American National Bank & Trust reduced its ResMed (RMD) stake by 0.62% in Q2 2026, selling an estimated $2.07K and leaving 1,612 shares worth $314K. The position accounts for 0.03% of the portfolio, ranked #194.
American National Bank & Trust first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.69M in Q3 2021. 206 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- American National Bank & Trust held 1,612 shares of ResMed worth $314K as of Q2 2026.
- American National Bank & Trust sold 10 ResMed shares in Q2 2026, an estimated $2.07K.
- ResMed made up 0.03% of American National Bank & Trust's portfolio in Q2 2026, its #194 holding.
- American National Bank & Trust first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
- American National Bank & Trust's ResMed position peaked at $1.69M in Q3 2021.
- 206 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.